passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital...
DESCRIPTION
In the middle of the 20th Century, pharmaceutical companies were highly respected and patients depended on their physicians to make healthcare decisions. Drugs were a key part of a physician’s ‘toolkit’. As we entered the era of the blockbuster drugs, most were small molecules made by chemical synthesis, but biotechnology was starting to emerge as a possible source of new therapeutics. Meanwhile, direct-to-consumer pharmaceutical advertising began to empower patients. Fast forward to today, and we see pharmaceutical companies suffering degraded reputations and values, patients further empowered by the Internet and social media, and average life expectancies increased by a decade. Digital health technologies are poised to explode and the top 10 pharmaceuticals by sales will soon all be biologicals!TRANSCRIPT
![Page 1: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/1.jpg)
Passing the Healthcare Innovation Torch:From Medicinal Chemistry through Biotechnology to Digital Technology
Frontiers of MedicineMaRS
8 May 2013Martin Sumner-Smith
![Page 2: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/2.jpg)
About me
Martin Sumner-Smith, PhD
Academic – Biotechnology – Bioinformatics – Enterprise – Advisory
1970’s 1980’s 1990’s 2000’s 2010’s
![Page 4: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/4.jpg)
Global Core Systems
The world’s 4 trillion dollar challenge, Using a system-of-systems approach to build a smarter planet – IBM
![Page 5: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/5.jpg)
![Page 6: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/6.jpg)
Inefficiency in Healthcare
The world’s 4 trillion dollar challenge, Using a system-of-systems approach to build a smarter planet – IBM
![Page 7: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/7.jpg)
![Page 8: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/8.jpg)
Pharmaceuticals
Digital Health
Biotechnology
Medicinal Chemistry
![Page 9: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/9.jpg)
“…the industry has seen itself as an independent product supplier to healthcare
rather than as an integrated part of, and collaborator with, the other participants in the
ecosystem.”
Fade or flourish? Rethinking the role of life sciences companies in the healthcare ecosystem – IBM
![Page 10: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/10.jpg)
Market Growth
![Page 11: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/11.jpg)
Patent Expiry
Fade or flourish? Rethinking the role of life sciences companies in the healthcare ecosystem – IBM
![Page 12: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/12.jpg)
Declining R&D productivity
Fade or flourish? Rethinking the role of life sciences companies in the healthcare ecosystem – IBM
![Page 13: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/13.jpg)
R&D Success vs. Expenditure
Identifying R&D outliersPeter Tollman, Yves Morieux, Jeanine Kelly Murphy & Ulrik SchulzeNature Reviews Drug Discovery 10, 653-654 (September 2011)
![Page 14: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/14.jpg)
Identifying R&D outliersPeter Tollman, Yves Morieux, Jeanine Kelly Murphy & Ulrik SchulzeNature Reviews Drug Discovery 10, 653-654 (September 2011)
![Page 15: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/15.jpg)
http://www.lek.com/sites/default/files/in_vivo_new_face_of_blockbuster_drugs_l.e.k.pdf
![Page 16: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/16.jpg)
Life Sciences Industry Trends…
• Blockbuster era comes to an end• Strong sales growth but declining expectations
P/E for large-cap biopharma fell from 35x in 2000 to 11x in 2010
Pricing and access pressures Higher scientific hurdles More stringent regulatory hurdles Increased competition R&D actually destroys value in some
organizations!
![Page 17: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/17.jpg)
Slide 18
Time
Mar
ket
Gro
wth
Technology AdoptionLife Cycle
GrowthMarket Mature
MarketDecliningMarket
Indefinitely elasticmiddle period
End of Life
A
FaultLine!
E
D
C
B
The Category Maturity Lifecycle
Category Lifecycle
![Page 18: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/18.jpg)
Slide 19
ExperientialInnovation
MarketingInnovation
Innovation Types for Mature Markets – Customer Intimacy Zone
Customer Intimacy Zone
EnhancementInnovation
Line ExtensionInnovation
There are four types of innovation in the Customer Intimacy Zone
![Page 19: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/19.jpg)
Slide 20
Market Access
• Moore describes this further market development as ‘fractilization’ of core markets
PC
![Page 20: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/20.jpg)
1970’s 1980’s 1990’s 2000’s 2010’s
First DTG in 1981Merck’s Pneumovax in Reader’s Digest
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278148/
![Page 22: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/22.jpg)
![Page 23: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/23.jpg)
Average Life Expectancy
https://www.google.ca/publicdata
![Page 24: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/24.jpg)
TRIZ
Genrich Altshuller:“Theory of Inventive Problem Solving”
1. Problems and solutions are repeated across industries and sciences
2. Patterns of technical evolution are also repeated across industries and sciences
3. Innovations used scientific effects outside the field in which they were developed
http://en.wikipedia.org/wiki/TRIZ
![Page 26: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/26.jpg)
http://www.lek.com/sites/default/files/in_vivo_new_face_of_blockbuster_drugs_l.e.k.pdf
![Page 27: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/27.jpg)
http://www.lek.com/sites/default/files/in_vivo_new_face_of_blockbuster_drugs_l.e.k.pdf
![Page 28: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/28.jpg)
Therapeutic Foci
Fade or flourish? Rethinking the role of life sciences companies in the healthcare ecosystem – IBM
![Page 29: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/29.jpg)
Market Leading “Pharmaceuticals”
• In 2012 the top pharmaceutical was a biological for the first time Abbvie’s HUMIRA
• “By 2020 the top 10 pharmaceuticals will all be biologicals” – Steve Burrill
![Page 30: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/30.jpg)
Sales Erosion after Patent Expiry
Small Molecule
Biologicals
Measuring the return from innovation: Is R&D earning its investment? – Deloitte
![Page 31: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/31.jpg)
Ultra-Orphans
http://www.forbes.com/sites/matthewherper/2012/09/05/how-a-440000-drug-is-turning-alexion-into-biotechs-new-innovation-powerhouse/
Alexion’s Soliris
![Page 32: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/32.jpg)
R&D Innovation
• Rising costs, especially sunk cost for failures Late stage failure rates too high
• Declining output Need to simplify operations
• Costs 7x in 25 years Cost per new drug now $1.1 - 1.7 billion Slow pace of discovery and validation Inefficient patient recruitment
• 80% miss deadlines, average 90 day delay Complex analysis required for trial termination
![Page 33: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/33.jpg)
RiskMitigation
The future of the life sciences industries:Transformation amid rising risk – Deloitte
![Page 34: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/34.jpg)
http://www.forbes.com/sites/johnnosta/2013/04/16/digital-health-will-pharma-follow-or-lead/
![Page 35: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/35.jpg)
Life Sciences Industry Trends
• Traditionally:A high-risk, high-margin business
• But increasing pressures:• Loss of patent protection & competition from generics• Costs of innovation and R&D skyrocketing• Reimbursement ceiling and demands• Increased transparency required by regulators & others
• Drive a move to:Managed risk and more conservative
margins
![Page 36: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/36.jpg)
“The life sciences industry stands at a crossroads.Its business model is broken,
and the surrounding healthcare ecosystem is changing dramatically.
So how should companies respond?
They can carry on as normal andpotentially fade into insignificance
or completely rethink how they engage with theother stakeholders in the healthcare ecosystem in an
effort to flourish anew.”
Fade or flourish? Rethinking the role of life sciences companies in the healthcare ecosystem – IBM
![Page 37: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/37.jpg)
“…you can’t meet the challenges of tomorrow with yesterday’s tools—and expect to survive.”
The future of the life sciences industries: Transformation amid rising risk– Deloitte
![Page 38: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/38.jpg)
Pharmaceuticals
Digital Health
Biotechnology
Medicinal Chemistry
![Page 39: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/39.jpg)
“One of the key drivers for the future lies in using information to create more personalised care and
standardisation at the same time. We are witnessing the ‘industrial revolution’ of healthcare, enabled by IT”
– PA Consulting
![Page 40: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/40.jpg)
“And while the industry remains data rich, it is weaker when it comes to turning data into insights.”
Fade or flourish? Rethinking the role of life sciences companies in the healthcare ecosystem – IBM
![Page 41: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/41.jpg)
![Page 42: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/42.jpg)
From vision to decision: Pharma 2020 – pwc
![Page 43: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/43.jpg)
Engaging the Patient
http://www.ted.com/talks/jamie_heywood_the_big_idea_my_brother_inspired.html
Customer Experience
Management
![Page 44: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/44.jpg)
“The shifting trend in pharma towards increased adoption of IT beyond their traditional needs and
exploring new IT avenues in digital marketing, regulatory submissions, predictive analysis & cloud computing has become more evident in the last few
years.”
IT Life Sciences Summit 2012: Technology Enabled Pharmaceutical Business Transformation – DIA
![Page 45: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/45.jpg)
Cha
nge
Time
Achieved
Expected
![Page 46: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/46.jpg)
![Page 47: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/47.jpg)
Gartner’s Hype Cycle
![Page 48: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/48.jpg)
Source: http://www.infoq.com/news/2012/08/Gartner-Hype-Cycle-2012
![Page 49: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/49.jpg)
![Page 50: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/50.jpg)
![Page 51: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/51.jpg)
![Page 52: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/52.jpg)
![Page 53: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/53.jpg)
http://rockhealth.com/2013/04/2013-digital-health-funding-update/
![Page 54: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/54.jpg)
![Page 56: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/56.jpg)
Smartphone/Tablet base features
• Processor• Local and Cloud storage• Distant communication• Time• Location• Activity• Local communication• Camera…
![Page 57: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/57.jpg)
![Page 58: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/58.jpg)
Wearables
IMS estimates $14 million in 2011 rising to $171 million by 2016
![Page 59: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/59.jpg)
Add-ons
![Page 60: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/60.jpg)
![Page 61: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/61.jpg)
Proteus Digital Health
![Page 62: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/62.jpg)
The Internet of things – M2M
![Page 63: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/63.jpg)
![Page 64: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/64.jpg)
![Page 65: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/65.jpg)
Watson
![Page 66: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/66.jpg)
![Page 67: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/67.jpg)
Where do the data go?
![Page 68: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/68.jpg)
![Page 69: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/69.jpg)
Synergy
“At 8:03am you used your asthma puffer while entering the MaRS concourse,
walking at a moderate pace towards the Tim Horton’s after an unusually long
subway ride. Your pulse was 110, blood pressure 135/80, temperature 37.2, blood
glucose…”
![Page 70: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/70.jpg)
“Based on data collected to date I estimate that there is 78.9% probability of an allergen to
which you react present at the following locations…”
![Page 71: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/71.jpg)
Patient empowerment trends
![Page 72: Passing the healthcare innovation torch: from medicinal chemistry, though biotechnology to digital technology](https://reader033.vdocuments.us/reader033/viewer/2022061110/54513858af795902348b5455/html5/thumbnails/72.jpg)
Thank you
Martin Sumner-Smith, PhD Email: [email protected] Office/Mobile: 1 (416) 727-4426Web: www.DigitalForHealth.comTwitter: @martinssLinkedin: http://ca.linkedin.com/in/martinss